Investigating HLA-E Peptide Binding on Natural Killer Cells for Targeting Breast Cancer Stem Cells
DOI:
https://doi.org/10.61173/59g8rk83Keywords:
-component, natural killer cells, immuno-therapy, breast cancer, Pmhc-HLA-EAbstract
-Breast cancer stem cells (BCSCs) are a major challenge for many conventional therapies such as chemotherapy and radiotherapy. Natural killer cells are often mentioned in immunotherapy, but the need for activation makes NK cell immunotherapy less than satisfactory. Recent studies have found that the MHC HLA-E protein has an abundant peptide expression that can activate NK cells. This study will focus on using HLA-E-expressed peptides in MHC proteins to activate NK cells and develop new possibilities for immunotherapy.
References
[1] Nagarajan, D. and S.E.B. McArdle, Immune Landscape of Breast Cancers. Biomedicines, 2018. 6(1).
[2] Barzaman, K., et al., Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol, 2020. 84: p. 106535.
[3] Mazloumi, Z., et al., A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis. Biochem Biophys Res Commun, 2023. 640: p. 50-55.
[4] Rafat, A., et al., Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways. Life Sciences, 2022. 295: p. 120402.
[5] Terrén, I., et al., NK Cell Metabolism and Tumor Microenvironment. Front Immunol, 2019. 10: p. 2278.
[6] Huisman, B.D., et al., High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation. Nat Commun, 2023. 14(1): p. 4809.
[7] Xu, L., et al., WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells. Int J Oncol, 2016. 48(3): p. 1175-1186.
[8] Zhong, W., et al., Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Dean&Francis Shuman Zhang Tumors. Cancer Res, 2023. 83(16): p. 2790-2806.
[9] Tsuchida, T. and S.L. Friedman, Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol, 2017. 14(7): p. 397-411.
[10] Retecki, K., et al., The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance. Cancers, 2021. 13(23): p. 6012.
[11] Kiany, S., G. Huang, and E.S. Kleinerman, Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis. OncoImmunology, 2017. 6(8): p. e1333214.
[12] Colombo J, Jardim-Perassi BV, Ferreira JPS, et al. Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells. Anticancer Agents Med Chem. 2018;18(12):1688-1694.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
